Treatment of Recurrent rectal Cancer

May 28, 2012

370 likes | 660 Views

Pain and quality of life after treatment in patients with locally recurrent rectal cancerEsnaola NF. Cantor SB. Johnson ML. Mirza AN. Miller AR. Curley SA. Crane CH. Cleeland CS. Janjan NA. Skibber JM. Journal of Clinical Oncology. 20(21):4361-7, 2002 Nov 1. . Article. Difficult treatment areaAf

Share Presentation

Embed Code

Link

cleveland

Download Presentation

Treatment of Recurrent rectal Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Multidisciplinary treatment of rectal cancer. Medical oncology

495 views • 24 slides

Treatment options for locally recurrent Prostate Cancer

Mediterranean School of Oncology Roma 15-06-2012. Treatment options for locally recurrent Prostate Cancer. Giuseppe Simone. Treatment options. Local recurrence after RP Radiotherapy ADT if N+ M+ Other options (off label). Treatment options. Local recurrence after Radiation treatments

418 views • 23 slides

Management of Locally Advanced Rectal Cancer

Management of Locally Advanced Rectal Cancer. Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007. Colorectal Cancer. Primary modality of treatment: Surgical Resection. Rectal Cancer. Middle and lower rectum Located in the confined pelvis

1.26k views • 53 slides

Rectal Cancer: Advanced Technologies

Rectal Cancer: Advanced Technologies. Chris Willett, M.D. Department of Radiation Oncology Duke University Medical Center Durham, NC. Gastric Intergroup 0116: RT Considerations. 35% of initially submitted RT plans: Major deviations (2/3 undertreatment) 2 D Therapy: AP/PA.

635 views • 37 slides

Treatment of Localized Rectal Cancer: Missteps and Next Steps

Treatment of Localized Rectal Cancer: Missteps and Next Steps. Hagen Kennecke, MD, MHA, FRCPC BC Cancer Agency – Vancouver Centre Atlantic Canada Oncology Group Symposium June 24, 2011. OBJECTIVES. Briefly review advances in rectal cancer therapy over the past 2 decades.

639 views • 42 slides

Emerging Paradigms in the Multimodality Treatment of Locally Advanced Rectal Cancer

Emerging Paradigms in the Multimodality Treatment of Locally Advanced Rectal Cancer. A. William Blackstock, Jr., MD Wake Forest University Comprehensive Cancer Center. Case Presentation. A 56 year old gentleman presents with several weeks of Hematochezia and 15 lbs weight loss

718 views • 40 slides

Consequences of Treatment for Rectal Cancer

Consequences of Treatment for Rectal Cancer. Gillian Knowles, Rachel Haigh, Catriona McLean, Hamish Phillips, Malcolm Dunlop, Farhat Din. Background. People can experience distressing symptoms following treatment for rectal cancer

406 views • 20 slides

Multidisciplinary treatment of rectal cancer. Medical oncology

Multidisciplinary treatment of rectal cancer. Medical oncology. Carlo Aschele E.O. Ospedali Galliera – Genova - Italy. ESMO CONFERENCE - LUGANO July 5-8 2007. Multidisciplinary treatment of rectal cancer. extraperitoneal rectal cancer locally advanced rectal cancer.

479 views • 22 slides

$Treatment of Recurrent Platinum-Refractory Ovarian Cancer$

Treatment of Recurrent Platinum-Refractory Ovarian Cancer

Treatment of Recurrent Platinum-Refractory Ovarian Cancer. Andreas du Bois Dept. Gynecology & Gynecologic Oncology Wiesbaden, Germany. AGO-OVAR Definitions of Platinum Sensitivity*. (potentially) platinum-sensitive disease: no prior chemotherapy

558 views • 20 slides

Surgical Treatment of the Low (Distal Third) Rectal Cancer

Surgical Treatment of the Low (Distal Third) Rectal Cancer. Feza H. Remzi FACS, FASCRS, FTSS ( Hon ) Chairman Department of Colorectal Surgery Professor of Surgery Rupert B Turnbull Jr,. MD Chair Digestive Disease Institute Cleveland Clinic, Cleveland, OH. Disclosure. None.

1.11k views • 73 slides

Multimodality Therapy of Rectal Cancer

Multimodality Therapy of Rectal Cancer. Robert D. Madoff, MD University of Minnesota. rectal cancer clinical issues. colostomy or anastomosis? local or radical surgery? functional outcomes? neoadjuvant therapy?. rectal cancer therapy. morbidity mortality function. optimal cure rate.

1.27k views • 75 slides

Rectal cancer

Rectal cancer. OLD APPROACH TO RECTAL CANCER. CURRENT APPROACH TO RECTAL CANCER. Surgical resection Pathology assessment and estimation of risk Treatment based upon classical TNM factors Postoperative concurrent chemo-radiation. Staging workup (MRI,TRUS,PET CT) MDT discussion

888 views • 36 slides

Chemoradiotherapy for Rectal cancer

Chemoradiotherapy for Rectal cancer. Dr. A . Sun Myint Lead Clinician GI Tumour Group Clatterbridge Centre for Oncology. Association of Coloproctology of Great Britain and Ireland M62 Coloproctology Course - March 23 rd 2007. Background.

1.17k views • 81 slides

Management of rectal cancer

Mediterranean School of Oncology Rome, November 23, 2012. Management of rectal cancer. CARMINE PINTO Oncologia Medica Policlinico S.Orsola-Malpighi Bologna. Background - 1.

1.17k views • 82 slides

Colon Rectal Cancer

They immediately put 74 cc back into me, via an IV drip. The remaining 6 cc will be expanded to increase the number of stem cells from approximately 5 million to 100-200 million. Half to all of the expanded cells will be put back into me again, via IV with the other half to be frozen for future use.

204 views • 15 slides

Treatment options for locally recurrent Prostate Cancer

235 views • 23 slides

CPAC Rectal Cancer Project

CPAC Rectal Cancer Project. The webinar will begin momentarily. All participant lines will be muted during the presentations. Following the presentations, all participant lines will be unmuted for discussion and question period. CPAC Rectal Cancer Project (2014-2017).

504 views • 46 slides

Palbociclib—A breakthrough in the treatment of recurrent ovarian cancer

There is not much that can help to treat recurrent metastatic ovarian cancer effectively. Recently, Ibrance Palbociclib has been approved to treat this condition in patients who have previously undergone cytotoxic chemotherapy and hormone therapy. It is a cyclin-dependent kinase inhibitor that blocks the action of CDK4 and CDK6 on the cancer cells and curbs their growth.

45 views • 4 slides

More Related